Skip to main content
. 2012 Oct 10;92(2):231–238. doi: 10.1007/s00277-012-1592-1

Table 2.

Point prevalence of definite and probable Pneumocystis pneumonia according to the number of cycles of R-CHOP chemotherapy

Category Cycle number of R-CHOP No. of patients on each cycle of R-CHOP No. of patients censored before the cycle Number of patients with PCP Point prevalence
Per 1000 persons 95 % confidence interval
Definite only (N = 14) 1 713 1 1.40 0.20–9.96
2 670 43 1 1.49 0.21–10.60
3 649 21 0 0 Not applicable
4 578 71 3 5.19 1.67–16.10
5 493 85 5 10.14 4.22–23.47
≥ 6 456* 37 4 8.93 3.35–24.79
Definite & probable (N = 32) 1 713 1 1.40 0.20–9.96
2 670 43 6 8.96 4.02–19.93
3 646 24 3 4.64 1.50–14.40
4 575 71 8 13.91 6.96–27.82
5 490 85 6 12.24 5.50–27.26
≥ 6 453 37 8 17.66 8.83–35.31

* Of 456 patients, 371, 11, and 74 patients received 6, 7, and 8 cycles of R-CHOP, respectively. Of 453 patients, 368, 11, and 74 patients received 6, 7, and 8 cycles of R-CHOP, respectively. Abbreviations: PCP: Pneumocystis pneumonia